Sickle cell disease vaso-occlusive crisis research hub

A Phase 2 / Phase 3, Multicenter, Randomized, Multiple-Dose, Double-Blind, Placebo-Controlled Adaptive Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents with Sickle Cell Disease during Vaso-Occlusive Crisis

This study is looking at a new medicine called CSL889 for people having a sickle cell pain crisis. We want to see if it's safe, helps reduce pain faster, and how the body uses it compared to a sham treatment.